Company Filing History:
Years Active: 2025
Title: Kenian Yan: Innovator in Pharmaceutical Chemistry
Introduction
Kenian Yan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on isoindoline compounds. His research focuses on developing novel compounds that can be utilized in treating various diseases.
Latest Patents
Kenian Yan holds a patent for an isoindoline compound, which includes a preparation method, pharmaceutical composition, and its uses. The invention relates to a polysubstituted isoindoline compound, which is a class of novel CRL4E3 ubiquitin ligase modulators. This compound exhibits stronger antitumor activity and a broader antitumor spectrum, making it a promising candidate for drug development aimed at treating CRL4E3 ligase-related diseases. He has 1 patent to his name.
Career Highlights
Kenian Yan is affiliated with the Chinese Academy of Sciences, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment and drug development. His innovative approach to pharmaceutical chemistry has positioned him as a key figure in his field.
Collaborations
Kenian collaborates with notable colleagues, including Xiaohua Chen and Jia Li. Their combined expertise enhances the research efforts at the Chinese Academy of Sciences, fostering an environment of innovation and discovery.
Conclusion
Kenian Yan's contributions to the field of pharmaceutical chemistry, particularly through his patented isoindoline compound, highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds the potential for significant medical breakthroughs.